Area of research
Complementary and alternative medicine · Cardiology and Cardiovascular Medicine
Research interest
Research focused on Decoction and Traditional Chinese medicine, with related work in Pharmacology, Cardioprotection, Naringenin. Notable publications include 'Salvianolic acid B protects against myocardial ischaemia-reperfusion injury in rats via inhibiting high mobility group box 1 protein expression through the PI3K/Akt signalling...', 'Characterization of chemical profile and quantification of major representative components of Wendan decoction, a classical traditional Chinese medicine formula', and 'Naringenin Inhibits Platelet Activation and Arterial Thrombosis Through Inhibition of Phosphoinositide 3-Kinase and Cyclic Nucleotide Signaling'.
Corrigendum to “Pharmacokinetics integrated with network pharmacology to clarify effective components and mechanism of Wendan decoction for the intervention of coronary heart disease” [J. Ethnopharmacol. 314 (2023) 116669]
RETRACTED: Treatment of diabetic foot ulcers with external application of Chinese herbal medicine: An overview of overlapping systematic reviews
Interim Analysis Report of Kuanxiong Aerosol in Improving Angina and Quality of Life after Percutaneous Coronary Intervention
Metabolic profile and potential mechanisms of Wendan decoction on coronary heart disease by ultra‐high‐performance quadrupole time of flight‐mass spectrometry combined with network pharmacology analysis
Kakonein restores hyperglycemia-induced macrophage digestion dysfunction through regulation of cathepsin B-dependent NLRP3 inflammasome activation
Correlation between Characteristics of Coronary Plaque and Chinese Medicine Syndromes of Coronary Heart Disease: A Cross-Sectional Study Analysed by Intravascular Ultrasound
Characterization of chemical profile and quantification of major representative components of Wendan decoction, a classical traditional Chinese medicine formula
Naringenin Inhibits Platelet Activation and Arterial Thrombosis Through Inhibition of Phosphoinositide 3-Kinase and Cyclic Nucleotide Signaling
Prevention of platelet aggregation and arterial thrombosis using a modified Shenzhu Guanxin Formula
Salvianolic acid B protects against myocardial ischaemia-reperfusion injury in rats via inhibiting high mobility group box 1 protein expression through the PI3K/Akt signalling pathway
The efficacy and safety of Shenzhu Guanxin Recipe Granules for the treatment of patients with coronary artery disease: protocol for a double-blind, randomized controlled trial
Application evaluation of clinical practice guidelines for traditional Chinese medicine: a clinical analysis based on the analytic hierarchy process
The efficacy and safety of Shenzhu Guanxin Recipe Granules for treatment of patients with coronary artery disease: protocol for a double-blind, randomized controlled trial
3,7-Bis(2-hydroxyethyl)icaritin, a potent inhibitor of phosphodiesterase-5, prevents monocrotaline-induced pulmonary arterial hypertension via NO/cGMP activation in rats
Systems Pharmacology Dissection of Traditional Chinese Medicine Wen‐Dan Decoction for Treatment of Cardiovascular Diseases
Shenzhu Guanxin Recipe Granules (参术冠心方颗粒) for Improving Exercise Tolerance in Patients with Stable Angina (SERIES Trial): A Protocol of Multicenter, Randomized, Double-Blind, Placebo Parallel Controlled Clinical Trial
Ginsenoside Rb1 prevents homocysteine-induced EPC dysfunction via VEGF/p38MAPK and SDF-1/CXCR4 activation
Traditional Chinese Medicine ShenZhuGuanXin Granules Mitigate Cardiac Dysfunction and Promote Myocardium Angiogenesis in Myocardial Infarction Rats by Upregulating PECAM‐1/CD31 and VEGF Expression
Attenuation of ischemia/reperfusion-induced inhibition of the rapid component of delayed rectifier potassium current by Isosteviol through scavenging reactive oxygen species
Clinical therapeutic effect of Yindan Xin Nao Tong combined with diltiazem in treating coronary artery spasm
South China Journal of Cardiovascular Diseases 2013cited by 0position: first